Nishan M DeSilva

CIK 1492386 · VP, Finance & Strategy and CFO · last filed 2026-01-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.80M

Companies

4

Total Filings

19

Lifetime Open-Market Net

-$5.84M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RNAC Director 11,366 $9.51 $108.1K $0 4 2026-01-06
Cartesian Therapeutics, Inc. (SELB) Delisted Director 7,000 $0.88 $6.2K $20.7K 4 2023-01-04
LGND VP, Finance & Strategy and CFO 22,282 $255.54 $5.69M -$5.86M 7 2015-05-14
ALLOS THERAPEUTICS INC (ALTH) Delisted Director 35,000 $0 2 2011-12-15

Recent Filings · Page 2 of 2

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2014-02-14 LGND Grant (A) +3,000 $0 EDGAR
2013-07-01 LGND Buy (P) +169 $2.9K EDGAR
2013-02-19 LGND Grant (A) +5,000 $0 EDGAR
2013-01-03 LGND Other (J) +490 $7.1K EDGAR
2012-02-13 LGND Grant (A) +10,000 $0 EDGAR
2011-12-15 ALLOS THERAPEUTICS INC (ALTH) Delisted Grant (A) +35,000 $0 EDGAR
2011-06-23 ALLOS THERAPEUTICS INC (ALTH) Delisted Grant (A) $0 EDGAR
2011-04-05 Grant (A) $0
2010-08-03 Grant (A) $0
Showing 1119 of 19
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.